Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Cerebellar Ataxia: early-phase trial registry

3 of 6 indexed Cerebellar Ataxia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Cerebellar Ataxia: 6 US clinical trials tracked, 3 recruiting.

Cerebellar Ataxia is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, running 2 of these trials.

Enrollment posture brief

Registry condition cerebellar-ataxia

OPEN 3 | RECR 50% | LATE 0 | EARLY 1 | RANK #2866 | SPON 2

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Cerebellar Ataxia (this)50%
Open-enrollment share among volume-matched conditions near Cerebellar Ataxia

Cerebellar Ataxia lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cerebellar Ataxia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cerebellar Ataxia is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cerebellar Ataxia research.

    Hugo W. Moser Research Institute at Kennedy Krieger accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Cerebellar Ataxia trials plan to enrol fewer than 100 people.

    Median target enrolment is 30 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.

  4. Cerebellar Ataxia research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Cerebellar Ataxia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Speech-motor behavioral testing Behavioral
1 trials
Reach training with visual feedback Behavioral
1 trials
Home exercise Behavioral
1 trials
Physical activity coaching Behavioral
1 trials
Specimen collection Other
1 trials
MRI Diagnostic test
1 trials
Transcranial Magnetic Stimulation (TMS) Device
1 trials
TMS Device
1 trials

US sites by state

Facility locations filed on Cerebellar Ataxia trials. A trial with sites in several states counts in each.

Maryland 2 trials
Wisconsin 1 trials
Pennsylvania 1 trials
New York 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cerebellar Ataxia page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cerebellar Ataxia condition card totals 6 registered trials; most-linked intervention Speech-motor behavioral testing; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.